Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $810,977 |
Sells | 5 | $559,578 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
31 Jan 2024 18:29 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 31 Jan 2024 | Purchase | 27,460 | 3.9968 | 109,752 | D |
31 Jan 2024 18:29 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 29 Jan 2024 | Purchase | 31,541 | 3.7106 | 117,036 | D |
31 Jan 2024 18:29 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 30 Jan 2024 | Purchase | 40,999 | 3.9013 | 159,949 | D |
31 Jan 2024 18:28 | RLMD | RELMADA THERAPEUTICS Inc | SHENOUDA MAGED | Chief Financial Officer | 31 Jan 2024 | Purchase | 6,875 | 4.0645 | 27,943 | D |
31 Jan 2024 18:28 | RLMD | RELMADA THERAPEUTICS Inc | SHENOUDA MAGED | Chief Financial Officer | 30 Jan 2024 | Purchase | 15,000 | 3.8882 | 58,323 | D |
31 Jan 2024 18:28 | RLMD | RELMADA THERAPEUTICS Inc | SHENOUDA MAGED | Chief Financial Officer | 29 Jan 2024 | Purchase | 10,800 | 3.6528 | 39,450 | D |
31 Jan 2024 18:28 | RLMD | RELMADA THERAPEUTICS Inc | ENCE CHUCK | CA and CO | 30 Jan 2024 | Purchase | 14,500 | 3.8657 | 56,053 | D |
31 Jan 2024 18:28 | RLMD | RELMADA THERAPEUTICS Inc | ENCE CHUCK | CA and CO | 31 Jan 2024 | Purchase | 13,670 | 4.0548 | 55,429 | D |
31 Jan 2024 18:28 | RLMD | RELMADA THERAPEUTICS Inc | ENCE CHUCK | CA and CO | 29 Jan 2024 | Purchase | 10,800 | 3.6517 | 39,438 | D |
24 May 2023 09:00 | RLMD | RELMADA THERAPEUTICS Inc | O'GORMAN CEDRIC | Chief Medical Officer | 23 May 2023 | Purchase | 10,000 | 3.18 | 31,800 | D |
12 Dec 2022 20:00 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 08 Dec 2022 | Purchase | 55,250 | 2.096 | 115,804 | D |
05 Jul 2022 16:30 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 01 Jul 2022 | Sale | 4,068 | 18.32 | 74,526 | D |
05 Jul 2022 16:30 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 01 Jul 2022 | Sale | 8,848 | 18.45 | 163,246 | D |
05 Jul 2022 16:30 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 01 Jul 2022 | Sale | 839 | 18.48 | 15,505 | D |
05 Jul 2022 16:30 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 30 Jun 2022 | Sale | 10,698 | 19.01 | 203,369 | D |
05 Jul 2022 16:30 | RLMD | RELMADA THERAPEUTICS Inc | TRAVERSA SERGIO | Chief Executive Officer | 30 Jun 2022 | Sale | 5,314 | 19.37 | 102,932 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)